Seeking better outcomes for patients

CytRx Corporation is a biopharmaceutical company focused on the discovery and development of new therapeutics to treat patients with high unmet medical needs

Learn More

Want to learn more about cytrx?

View our company presentation

Latest News

Loading...
All News
 

CytRx has potential milestone/royalty payments and a subsidiary called Centurion BioPharma

Centurion BioPharma

CytRx may receive milestones and royalties from Orphazyme for arimoclomol

Orphazyme 2019 Objectives

Orphazyme development programs for arimoclomol

CytRx may receive milestones and royalties from NantCell/ImmunityBio for aldoxorubicin

CytRx partnered Pipeline with NantCell/ImmunityBio – aldoxorubicin